PTC Therapeutics appoints Pierre Gravier as CFO effective July 13, 2023

PTC THERAPEUTICS, INC.

Pierre Gravier, age 38, appointed CFO; previously managing director at Perella Weinberg Partners.
Annual base salary of $525,000; target annual bonus of 45% of base salary.
Received inducement equity: 26,000 RSUs (4-year vest) and option for 65,000 shares (4-year vest).
Severance: 15 months base salary plus health benefits if terminated without cause or for good reason.
Employment agreement includes perpetual confidentiality, 15-month non-compete/non-solicit.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Pierre Gravier

Chief Financial Officer

PTCT · PTC THERAPEUTICS, INC.

Effective: 2023-07-13
Filed: July 17, 2023, 7:59 PM ET

On July 13, 2023, the Board of Directors of PTC Therapeutics, Inc. (the “Company”) appointed Pierre Gravier, age 38, as Chief Financial Officer, effective as of July 13, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Pierre Gravier was appointed as Chief Financial Officer at PTC THERAPEUTICS, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On July 13, 2023, the Board of Directors of PTC Therapeutics, Inc. (the “Company”) appointed Pierre Gravier, age 38, as Chief Financial Officer, effective as of July 13, 2023.

View on SEC.gov

PTC THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001070081-23-000040

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.